cbdMD Receives Prestigious U.S. Hemp Authority™ Certification
cbdMD, Inc. (NYSE American: YCBD) has attained the U.S. Hemp Authority™ Certification, demonstrating its commitment to high-quality CBD products. This prestigious certification, awarded after a comprehensive third-party audit by Food Chain ID, allows cbdMD to use the Certified Seal on its product packaging, reinforcing its adherence to ISO and cGMP standards. The certification complements its NSF GMP registration, assuring consumers of the quality and safety of cbdMD's hemp-derived products. The company emphasizes its dual commitment to testing and quality management in providing trusted CBD solutions.
- Achieved U.S. Hemp Authority Certification, enhancing brand credibility.
- Certification allows use of the Certified Seal, boosting consumer confidence.
- Third-party audit validates adherence to ISO and cGMP standards.
- None.
cbdMD, Inc. (NYSE American: YCBD, YCBDpA), one of the nation’s leading and most highly trusted and recognized cannabidiol (CBD) brands, announced today that it has received the prestigious U.S. Hemp Authority™ Certification (USHA).
The certification signifies the Company's efforts to provide a high-quality, trustworthy product and grants the right to use the Certified Seal of the U.S. Hemp Authority on all hemp product packaging and marketing materials. In addition to the Company’s NSF GMP registration, the USHA Certification further validates that cbdMD adheres to the highest standards and provides consumers with the highest quality hemp extracted cannabinoid products.
Issued by leading food standards auditing company Food Chain ID, the USHA Certification includes a third party audit which covers topics such as maintaining a quality management system, meeting applicable ISO and cGMP standards, implementing standard operating procedures, and ensures compliance with relevant Federal regulations.
“We know that consumers choose cbdMD because of the commitment we make to the quality and safety of our products. As a market leader and leading recognized consumer CBD brand, it is critical that our consumers know that when they use a cbdMD product it is double-tested by third-party laboratories for purity and potency and that our manufacturing has been audited and validated to meet GMP by NSF, and now we have added the highly coveted U.S. Hemp Authority Certification,” said Martin Sumichrast, Chairman & Co-CEO of cbdMD, Inc.
About cbdMD, Inc.
cbdMD, Inc. is one of the leading and most highly trusted and most recognized cannabidiol (CBD) brands with a comprehensive line of U.S. produced, THC-free1 CBD products. Our cbdMD brand currently includes over 130 SKUs of high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD bath bombs, CBD bath salts, CBD sleep aids and CBD drink mixes. Our Paw CBD brand of pet products includes over 45 SKUs of veterinarian-formulated products including tinctures, chews, topicals products in varying strengths, and our CBD Botanicals brand of beauty and skincare products features 15 SKUs, including facial oil and serum, toners, moisturizers, clear skin, facial masks, exfoliants and body care. To learn more about cbdMD and their comprehensive line of U.S. grown, THC-free1 CBD oil products, please visit www.cbdmd.com, follow cbdMD on Instagram and Facebook, or visit one of the 6,000 retail outlets that carry cbdMD products.
1 THC-free is defined as below the level of detection using validated scientific analytical methods.
Forward-Looking Statements
This press release contains certain forward-looking statements that are based upon current expectations and involve certain risks and uncertainties within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements can be identified by the use of words such as ''should,'' ''may,'' ''intends,'' ''anticipates,'' ''believes,'' ''estimates,'' ''projects,'' ''forecasts,'' ''expects,'' ''plans,'' and ''proposes.'' These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading "Risk Factors" in cbdMD, Inc.'s Annual Report on Form 10-K for the fiscal year ended September 30, 2020 as filed with the Securities and Exchange Commission (the "SEC") on December 22, 2020, Item 1A. Risk Factors, contained in our Quarterly Report on Form 10-Q for the period December 31, 2020 as filed with the SEC on February 9, 2021 and our other filings with the SEC. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are generally outside the control of cbdMD, Inc. and are difficult to predict. cbdMD, Inc. does not undertake any duty to update any forward-looking statements except as may be required by law. The information which appears on our websites and our social media platforms, including, but not limited to, Instagram and Facebook, is not part of this press release.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210510005191/en/
